FIELD: microbiology.
SUBSTANCE: invention relates to microbiology and can be used for manufacturing of functional food products. Method of producing bacterial preparation with probiotic activity based on species of normal human intestinal microflora, involving extraction of bifidobacteria and lactobacilli from human excrements, their cultivation on liquid nutrient medium in anaerobic conditions at temperature 37 °C with subsequent centrifugation and separation of bacterial preparation. Excrements of adult healthy subject are used, who does not take antibiotic or probiotic preparations for 3 months before extraction, streptococci and enterococci are additionally extracted from excrements. Culturing is carried out on medium containing (g/l): yeast extract - 5.0; papain overcook of soya flour - 10.0; sodium hydrophosphate - 1.0; Tween-80 - 0.2; ammonium citrate - 1.0; cysteine hydrochloride - 0.5; magnesium chloride - 0.5; ascorbic acid - 0.5; glucose - 10.0; meat extract - 20.0; manganese sulphate - 0.05; sodium azide - 0.2. Or cultivation can be performed on medium containing (g/l): proteose peptone - 15.0; papain overcook of soya flour - 10.0; sodium hydrophosphate - 1.5; Tween-80 - 1.0; ammonium citrate - 2.0; cysteine hydrochloride - 1.0; magnesium chloride - 0.5; ascorbic acid - 0.2; sodium chloride - 2.5; glucose - 10.0; meat extract - 10.0; sodium azide - 0.2. Or cultivation can be performed on medium containing (g/l): yeast extract - 10.0; pancreatic hydrolysate of casein - 20.0; sodium hydrophosphate - 2.5; Tween-80 - 0.7; lactose - 5.0; ammonium citrate - 0.5; cysteine hydrochloride - 1.0; magnesium chloride - 1.0; ascorbic acid - 0.1; sodium acetate - 0.2; sodium chloride - 3.0; glucose - 5.0; meat extract - 15.0; manganese sulphate - 0.1; sodium azide - 0.2. Cultivation is performed till concentration of microorganisms reaches 1.0·108 COE/ml.
EFFECT: method enables to obtain probiotic preparation with antagonistic properties towards pathogenic and opportunistic pathogens, as well as antioxidant, hepatoprotective and anticancer activity.
1 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING A FUNCTIONAL FOOD FOR AFTERCARE OF ONCOLOGIC PATIENTS | 2016 |
|
RU2659240C2 |
METHOD FOR MANUFACTURING ENCAPSULATED FORM OF A PROBIOTIC FOOD SUPPLEMENT | 2021 |
|
RU2795965C1 |
METHOD OF SELECTIVE ALLOCATION OF AUTO STRAINS OF LACTOBACILLUS SPECIALES FROM CLINICAL MATERIAL | 2018 |
|
RU2675315C1 |
NUTRIENT ENVIRONMENT FOR RESTORING NUMBER OF ANAEROBIC BACTERIA AFTER LOW-TEMPERATURE STORAGE | 2017 |
|
RU2678123C1 |
PROBIOTIC PREPARATION FOR VIRAL AND BACTERIAL INFECTIONS TOXISPORIN, METHOD FOR PREPARING IT, BACILLUS LICHENIFORMIS BACTERIAL STRAIN USED AS INGREDIENT OF PROBIOTIC PREPARATION | 2011 |
|
RU2471864C1 |
METHOD FOR MICROORGANISM ISOLATION AND CULTURING | 2005 |
|
RU2279469C1 |
STRAIN OF MICROORGANISM LACTOBACILLUS PLANTARUM P4, STRAIN OF MICROORGANISM LACTOBACILLUS BUCHNERI P0 AND PROBIOTIC PREPARATION BASED ON THEREOF FOR CORRECTION OF DYSBACTERIOSIS OF DIFFERENT ETIOLOGY IN HUMANS AND ANIMALS | 2002 |
|
RU2247148C2 |
METHOD FOR OBTAINING A BACTERIOCIN-CONTAINING COMPOSITION | 2020 |
|
RU2773131C2 |
STRAIN OF MEYEROZYMA (PICHIA) GUILLIERMONDII (VARIANTS), USED FOR PRODUCING PRE-, PRO-, AND AUTOPROBIOTIC AGENTS AND PRODUCTS FOR HUMANS AND ANIMALS, THERAPEUTIC AND PREVENTIVE AGENT BASED THEREON, AND METHOD FOR PRODUCTION THEREOF (VARIANTS) | 2021 |
|
RU2771136C1 |
METHOD OF PRODUCING CAPSULAR FORM OF ANTIMICROBIAL AGENT FOR TREATING GASTROINTESTINAL DISORDERS | 2020 |
|
RU2743696C1 |
Authors
Dates
2016-12-27—Published
2015-04-28—Filed